Matches in SemOpenAlex for { <https://semopenalex.org/work/W2139156278> ?p ?o ?g. }
- W2139156278 endingPage "e35" @default.
- W2139156278 startingPage "e30" @default.
- W2139156278 abstract "1. Edward W. Fong, MD*2. Robert H. Levin, PharmD† 1. *Pediatric Pulmonologist, Children's Hospital and Research Center Oakland, Oakland, Calif., and California Pacific Medical Center, San Francisco, Calif2. †Professor Emeritus of Clinical Pharmacy, University of California San Francisco School of Pharmacy, San Francisco, CalifAsthma is an inflammatory disease of the respiratory tract. It is the most common chronic disorder in children and adolescents, with more than 3 million asthma attacks occurring in more than 5% of all children each year. Asthma creates significant morbidity and is the leading cause of school absences. Costs attributed to asthma are in the billions of dollars each year.All levels of persistent asthma require daily anti-inflammatory treatment, and the safest, most effective treatment for patients who have persistent asthma is inhaled corticosteroids (ICSs). Although steroids may be given orally or parenterally, and numerous nonsteroidal medications are available for treating persistent asthma, ICSs are the treatment of choice. Even when ICSs are given daily over a long period of time, they have less toxicity than oral or parenteral steroids administered only occasionally.This article reviews the currently available ICSs, devices and techniques for optimal administration, and potential adverse effects. The data and recommendations are based on the National Asthma Education and Prevention Program (NAEPP) guidelines (1991 and 1997) and Update 2002, which are available at http://www.nhlbi.nih.gov/guidelines/asthma.Asthma is a complex disorder whose pathogenesis is not fully understood. Current thinking is that susceptible individuals develop asthma because of an imbalance between the T-helper (Th)1 and Th2 lymphocytes. Th1 cells produce interleukin-2 (IL-2) and interferon-gamma, which act as a cellular defense mechanism, and Th2 cells produce cytokines (IL-4, IL-5, IL-6, IL-9, and IL-13), which mediate allergic inflammation. According to this current “hygiene hypothesis,” the Th1 cellular defense mechanism is reduced, while Th2 cellular activity increases. This imbalance predisposes the individual to episodes of chronic inflammatory asthma.Whatever triggers the pathogenesis sets up an inflammatory process in which many cellular components participate, including mast cells, T lymphocytes, eosinophils, neutrophils, and epithelial cells. The result is inflammation, hyperresponsiveness (bronchospasm), and in …" @default.
- W2139156278 created "2016-06-24" @default.
- W2139156278 creator A5061634166 @default.
- W2139156278 creator A5069404496 @default.
- W2139156278 date "2007-06-01" @default.
- W2139156278 modified "2023-10-14" @default.
- W2139156278 title "Inhaled Corticosteroids for Asthma" @default.
- W2139156278 cites W136652260 @default.
- W2139156278 cites W1922741640 @default.
- W2139156278 cites W1935602610 @default.
- W2139156278 cites W1963576616 @default.
- W2139156278 cites W1965677615 @default.
- W2139156278 cites W1967827648 @default.
- W2139156278 cites W1969199603 @default.
- W2139156278 cites W1969478334 @default.
- W2139156278 cites W1975028090 @default.
- W2139156278 cites W1976198657 @default.
- W2139156278 cites W1976322463 @default.
- W2139156278 cites W1982314879 @default.
- W2139156278 cites W1987571032 @default.
- W2139156278 cites W1989183270 @default.
- W2139156278 cites W1990744167 @default.
- W2139156278 cites W1991775872 @default.
- W2139156278 cites W1992846913 @default.
- W2139156278 cites W1995346107 @default.
- W2139156278 cites W2002266949 @default.
- W2139156278 cites W2005994055 @default.
- W2139156278 cites W2008109297 @default.
- W2139156278 cites W2010566912 @default.
- W2139156278 cites W2012358144 @default.
- W2139156278 cites W2013930428 @default.
- W2139156278 cites W2019259561 @default.
- W2139156278 cites W2025434594 @default.
- W2139156278 cites W2028762287 @default.
- W2139156278 cites W2036753543 @default.
- W2139156278 cites W2044699012 @default.
- W2139156278 cites W2050321519 @default.
- W2139156278 cites W2051022650 @default.
- W2139156278 cites W2052806182 @default.
- W2139156278 cites W2054891312 @default.
- W2139156278 cites W2062662734 @default.
- W2139156278 cites W2069849198 @default.
- W2139156278 cites W2077155334 @default.
- W2139156278 cites W2081776165 @default.
- W2139156278 cites W2082466693 @default.
- W2139156278 cites W2090116559 @default.
- W2139156278 cites W2091091085 @default.
- W2139156278 cites W2091464531 @default.
- W2139156278 cites W2098506864 @default.
- W2139156278 cites W2098680476 @default.
- W2139156278 cites W2098826581 @default.
- W2139156278 cites W2099917331 @default.
- W2139156278 cites W2106508230 @default.
- W2139156278 cites W2108073684 @default.
- W2139156278 cites W2110976010 @default.
- W2139156278 cites W2116134156 @default.
- W2139156278 cites W2121192844 @default.
- W2139156278 cites W2121230694 @default.
- W2139156278 cites W2124585444 @default.
- W2139156278 cites W2125158574 @default.
- W2139156278 cites W2132372821 @default.
- W2139156278 cites W2133115975 @default.
- W2139156278 cites W2133895139 @default.
- W2139156278 cites W2134902690 @default.
- W2139156278 cites W2139148381 @default.
- W2139156278 cites W2140889201 @default.
- W2139156278 cites W2145518541 @default.
- W2139156278 cites W2151937061 @default.
- W2139156278 cites W2155318134 @default.
- W2139156278 cites W2155440753 @default.
- W2139156278 cites W2159612708 @default.
- W2139156278 cites W2160477136 @default.
- W2139156278 cites W2170576139 @default.
- W2139156278 cites W2175340911 @default.
- W2139156278 cites W2183913543 @default.
- W2139156278 cites W2322866941 @default.
- W2139156278 cites W2341674111 @default.
- W2139156278 cites W2396981591 @default.
- W2139156278 cites W2585717783 @default.
- W2139156278 cites W2594805288 @default.
- W2139156278 cites W2949704572 @default.
- W2139156278 cites W1794581424 @default.
- W2139156278 cites W2418431792 @default.
- W2139156278 doi "https://doi.org/10.1542/pir.28-6-e30" @default.
- W2139156278 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17545330" @default.
- W2139156278 hasPublicationYear "2007" @default.
- W2139156278 type Work @default.
- W2139156278 sameAs 2139156278 @default.
- W2139156278 citedByCount "13" @default.
- W2139156278 countsByYear W21391562782012 @default.
- W2139156278 countsByYear W21391562782013 @default.
- W2139156278 countsByYear W21391562782015 @default.
- W2139156278 countsByYear W21391562782017 @default.
- W2139156278 countsByYear W21391562782018 @default.
- W2139156278 countsByYear W21391562782022 @default.
- W2139156278 countsByYear W21391562782023 @default.
- W2139156278 crossrefType "journal-article" @default.
- W2139156278 hasAuthorship W2139156278A5061634166 @default.